How science conquered COVID-19: from big platform trials to patients

Hot topics
Chairs: A. Simonds (London, United Kingdom), W. Randerath (Solingen, Germany)
Aims: To describe ground-breaking news about phenotyping and managing acute hospitalised COVID patients; to describe several key studies, results and advances including the recent RECOVERY-RS study of respiratory support, phenotyping to assist risk stratification and the results of the international RECOVERY and REMAP-CAP trials.

Phenotypes in acute COVID: lessons from the multicentre studies C. Summers (Cambridge (Cambridgeshire), United Kingdom)
Needing oxygen in COVID? Acute respiratory support (RECOVERY-RS), continuous positive airway pressure, high-flow nasal oxygen and other approaches controversies G. Perkins (Birmingham (West Midlands), United Kingdom)
Research prioritisation in long COVID: using patients and experts to develop an international consensus L. Daines (Edinburgh (Edinburgh), United Kingdom)
What have we learned from big platform trials of COVID? RECOVERY, REMAP-CAP and others L. Derde (Utrecht, Netherlands)
Discussion and Q&A